Disc DegenerationNCT06025175
Low Level Lazer Therapy Effect on Vertebral Artery Blood Flow in Elderly With Cervical Disc Degeneration
A study testing Low level Lazer therapy and Routine exercises in people with Disc Degeneration, run by South Valley University at 1 site in Egypt.
Trial summary
This study will include 60 elderly patients with cervical disc degeneration, from both gender who are aged from 60 - 75 years old. Read more about this study
- Who is it for?
- Ages 60 to 75 yearsHealthy volunteers can take part
- Conditions the study is for
- Disc Degeneration
- What is being tested?
- Low level Lazer therapy and Routine exercises
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteEgypt
- Study dates
- 15 Sep 2023to 1 Jan 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 to 75 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- elderly patients with age range between 60 and 75 years old.
- with cervical disc degeneration.
Who cannot join
- patients with uncontrolled hypertension.
- Patients with uncontrolled diabetes mellitus.
- Patients with severe cardiac or chest diseases.
Trial locations and contacts
1 site in 1 country.
Egypt1 site
Shymaa yussuf abo zaid
Qina
Shymaa Y Abo zaid, Doctoral, 01010941685 ext. 01091631018, shaymaayoussef397@gmail.com
Shymaa Y Abo zaid, Doctoral, 01010941685 ext. 01010941685
About this study
This study will include 60 elderly patients with cervical disc degeneration, from both gender who are aged from 60 - 75 years old.
Read the detailed description
The 60 patients will divided into two groups, with 30 patients in each group. group(A): will receive low level lazer and exercises for three times per week for 12 weeks.
Group (B): will receive only exercises. Resistivity index of both right and left vertebral arteries will be measured before and after the 12 weeks.
- Conditions
- Disc Degeneration
- Being tested
- Low level Lazer therapy, Routine exercises
- Medical subject headings
- Intervertebral Disc Degeneration
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Low level Lazer therapyRadiation
30 patients will receive low level lazer therapy 3 times a week for 12 weeks.
Routine exercisesOther
30 patients will receive only routine exercises 3 times a week for 12 weeks.
| Study group | Role | What they receive |
|---|---|---|
| Lazer group | Experimental | 30 patients will receive low level lazer therapy 3 times per week for 12 weeks. Receives: Radiation: Low level Lazer therapy; Other: Routine exercises |
| Control group | Other | 30 patients will receive only exercises. Receives: Other: Routine exercises |
What is being measured
The primary outcome is the main question the study is designed to answer.
Resistivity index of both right and left vertebral arteries
Resistivity index of both right and left vertebral arteries will be measured before and after the 12 weeks.
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Sep 2023
- Study start15 Sep 2023 (estimated)
- Primary completion1 Oct 2023 (estimated)
- Study completion1 Jan 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Disc DegenerationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Two groups Group (A) and group(B)
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- South Valley University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Shymaa yussuf abo zaid, South Valley University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06025175
- Sponsor's protocol ID
- P.T_int_08/2023_519
- Status last verified
- Sep 2023
- First submitted
- 20 Aug 2023
- Last updated
- 6 Sep 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Sep 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Low Level Lazer Therapy Effect on Vertebral Artery Blood Flow in Elderly With Cervical Disc Degeneration
- ClinicalTrials.gov ID
- NCT06025175
- Acronym / sponsor ID
- P.T_int_08/2023_519
- Conditions
- Disc Degeneration
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- South Valley UniversityUniversity, hospital or other
- Study start
- 15 Sep 2023 (estimated)
- Primary completion
- 1 Oct 2023 (estimated)
- Study completion
- 1 Jan 2024 (estimated)
- First posted
- 6 Sep 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study will include 60 elderly patients with cervical disc degeneration, from both gender who are aged from 60 - 75 years old.
Detailed description
The 60 patients will divided into two groups, with 30 patients in each group. group(A): will receive low level lazer and exercises for three times per week for 12 weeks.
Group (B): will receive only exercises. Resistivity index of both right and left vertebral arteries will be measured before and after the 12 weeks.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Two groups Group (A) and group(B)
| Arm | Type | Receives |
|---|---|---|
| Lazer group | Experimental | Radiation: Low level Lazer therapy, Other: Routine exercises30 patients will receive low level lazer therapy 3 times per week for 12 weeks. |
| Control group | Other | Other: Routine exercises30 patients will receive only exercises. |
Who may qualify
- Ages
- 60 to 75 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- elderly patients with age range between 60 and 75 years old.
- with cervical disc degeneration.
Key exclusion criteria (3 listed)
- patients with uncontrolled hypertension.
- Patients with uncontrolled diabetes mellitus.
- Patients with severe cardiac or chest diseases.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Low level Lazer therapy30 patients will receive low level lazer therapy 3 times a week for 12 weeks. | Radiation | Lazer group |
| Routine exercises30 patients will receive only routine exercises 3 times a week for 12 weeks. | Other | Control group, Lazer group |
Primary outcome
Resistivity index of both right and left vertebral arteries
Time frame: 12 weeks
Resistivity index of both right and left vertebral arteries will be measured before and after the 12 weeks.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Sep 2023.
Related trials for Disc Degeneration
Active, not recruiting
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
Degenerative Disc Disease, Spine Fusion
Not yet recruitingObservational study
Relationship Between Disability, Flexibility, Back Muscles, and Thoracolumbar Fascia in Patients With Lumbar Disc Degeneration
Intervertebral Disc Degeneration
Active, not recruiting
The Synergy Disc for the Treatment of 2 Level Cervical Degenerative Disc Disease Compared With Cervical Fusion Surgery
Cervical Degenerative Disc Disease
Active, not recruiting
ASCEND: A Clinical Trial to Evaluate the Safety and Effectiveness of VIA Disc NP, a Supplement for Degenerated Intervertebral Discs
Degenerative Disc Disease, Disc Degeneration
RecruitingObservational study
OssDsign® Spine Registry Study ("Propel")
Degenerative Disc Disease, Spinal Stenosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Low level Lazer therapy and Routine exercises in people with Disc Degeneration, run by South Valley University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 6 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Shymaa Y Abo zaid (01010941685 ext. 01091631018, shaymaayoussef397@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Resistivity index of both right and left vertebral arteries (time frame: 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Sep 2023; AzTrials last refreshed its copy on 6 Nov 2026.